Journal of Experimental Medicine

Since its establishment in 1896, the Journal of Experimental Medicine (JEM) has steadfastly pursued the publication of enduring and exceptional studies in medical biology. In an era where numerous publishing groups are introducing specialized journals, we recognize the importance of offering a distinguished platform for studies that seamlessly integrate various disciplines within the pathogenesis field. Our unique editorial system, driven by a commitment to exceptional author service, involves two collaborative groups of editors: professional editors with robust scientific backgrounds and full-time practicing scientists. Each paper undergoes evaluation by at least one editor from both groups before external review. Weekly editorial meetings facilitate comprehensive discussions on papers, incorporating external referee comments, and ensure swift decisions without unnecessary demands for extensive revisions. Encompassing human studies and diverse in vivo experimental models of human disease, our focus within medical biology spans genetics, inflammation, immunity, infectious disease, cancer, vascular biology, metabolic disorders, neuroscience, and stem cell biology. We eagerly welcome reports ranging from atomic-level analyses to clinical interventions that unveil new mechanistic insights.

Journal of Experimental Medicine（JEM）创刊于1896 年，该刊始终坚持发表医学和生物学领域经久不衰的杰出研究成果。在众多出版集团纷纷推出专业期刊的时代，我们认识到为发病机理领域各学科的研究提供一个杰出平台的重要性。我们独特的编辑系统致力于为作者提供卓越的服务，包括两个合作编辑小组：具有深厚科学背景的专业编辑和全职执业科学家。每篇论文在进行外部评审之前，都要经过两组编辑中至少一位编辑的评估。每周一次的编辑会议有助于对论文进行全面讨论，纳入外部审稿人的意见，确保迅速做出决定，避免不必要的大量修改。我们在医学生物学领域的研究重点涵盖遗传学、炎症、免疫、传染病、癌症、血管生物学、代谢紊乱、神经科学和干细胞生物学，包括人体研究和各种人体疾病实验模型。我们热切欢迎从原子级分析到临床干预等揭示新机理的报告。